Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Pharmaceuticals</strong> <strong>Ltd</strong>.year ended 31st March 20<strong>11</strong>Year Ended31st March 20<strong>11</strong>(` in Lacs)Year Ended31st March 20<strong>10</strong>SCHEDULE 18RESERCH & DEVELOPMENTR & D Chemicals & Expenses 66.35 78.96Manufacturing charges 0.29 -Power, Fuel and Electricity <strong>11</strong>.21 9.54Salaries, Wages and Allowances 320.02 338.83 14.03 13.75Staff Welfare 17.86 14.61Communication 0.69 1.25Conveyance 2.75 2.82Vehicles Maintenance 2.35 3.68435.55 463.44SCHEDULE 19INTEREST & FINANCE CHARGES :To Bank and Financial Institution 2806.92 1648.07To Others 3744.19 3654.016,551.<strong>11</strong> 5,302.08SCHEDULES FORMING PART OF THE CONSOLILDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED MARCH 31, 20<strong>11</strong>SCHEDULE 20NOTES ON ACCOUNTS:1. SIGNIFICANT ACCOUNTING POLICIES:i. Basis of Accounting Policies:the Companies (Accounting SAct, 1956.ii.Use of Estimates:Aprospectively in the current and future periods.iii. Principles of Consolidation:as that of the parent company i.e. year ended March 31, 20<strong>11</strong>.90
Change language